Cassy Workman
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Emergency Medicine top 0.5%
- HIV-related health complications and treatments
Papers in
-
- HIV/AIDS drug development and treatment 13
- HIV/AIDS Research and Interventions 4
- Virology 11
- HIV Research and Treatment 10
- Co-authors
- Jean‐Michel Molina (4 shared papers)David Nolan (2 shared papers)Sorin Rugină (3 shared papers)S. Mallal (3 shared papers)Janez Tomažič (3 shared papers)Arlene R. Hughes (2 shared papers)О. А. Козырев (2 shared papers)Alastair Benbow (3 shared papers)
- Journals
- AIDS (5 papers)Antiviral Therapy (2 papers)Current HIV Research (2 papers)The Medical Journal of Australia (2 papers)Human Vaccines (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Cassy Workman
30 papers receiving 2.6k citations
Cassy Workman's Hit Papers
Peers
Comparison fields: 5 of 86
- Virology 907
- Emergency Medicine 487
- Infectious Diseases 969
- Pharmacology 348
- Pharmacology 525
Countries citing papers authored by Cassy Workman
This map shows the geographic impact of Cassy Workman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cassy Workman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cassy Workman more than expected).
Fields of papers citing papers by Cassy Workman
This network shows the impact of papers produced by Cassy Workman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cassy Workman. The network helps show where Cassy Workman may publish in the future.
Co-authors
The 25 scholars most cited alongside Cassy Workman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HLA-B*5701 Screening for Hypersensitivity to Abacavir Hit paper breakdown → | 2008 | 1192 |
| 2 | 2001 | 360 | |
| 3 | 2004 | 240 | |
| 4 | 2009 | 200 | |
| 5 | 2004 | 186 | |
| 6 | 2011 | 76 | |
| 7 | 2006 | 67 | |
| 8 | 2000 | 58 | |
| 9 | 1998 | 42 | |
| 10 | 2012 | 39 | |
| 11 | 2000 | 34 | |
| 12 | 2008 | 27 | |
| 13 | 2008 | 27 | |
| 14 | 2007 | 24 | |
| 15 | 2006 | 22 | |
| 16 | 2005 | 22 | |
| 17 | 2007 | 15 | |
| 18 | 2002 | 13 | |
| 19 | 2006 | 9 | |
| 20 | 1994 | 8 |
About Cassy Workman
Cassy Workman is a scholar working on Infectious Diseases, Virology, Epidemiology, Immunology and Emergency Medicine, having authored 30 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (13 papers), HIV Research and Treatment (10 papers), HIV-related health complications and treatments (5 papers), Drug-Induced Adverse Reactions (4 papers), HIV/AIDS Research and Interventions (4 papers), Immune Cell Function and Interaction (3 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Herpesvirus Infections and Treatments (2 papers). The work is most often cited by research in Virology (907 citations), Emergency Medicine (487 citations), Infectious Diseases (969 citations), Pharmacology (348 citations) and Pharmacology (525 citations). Cassy Workman has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Jean‐Michel Molina, David Nolan, Sorin Rugină, S. Mallal, Janez Tomažič, Arlene R. Hughes, О. А. Козырев, Alastair Benbow, D. Thorborn and E. Jägel-Guedes. Their work appears in journals such as AIDS, Antiviral Therapy, Current HIV Research, The Medical Journal of Australia and Human Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.